Company profile FENC
After 39 days of this quarter the interest is at 47.0. Based on that we can calculate that during remaining 52 days it will total up to 110.0. Fennec Pharmaceuticals expected interest is significantly higher compared to same quarter last year (+134.0%) but similar to previous quarter.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 12 | 46 283.3% QoQ | 53 15.2% QoQ | 60 13.2% QoQ |
| 2020 | 27 125.0% YoY -55.0% QoQ | 87 89.1% YoY 222.2% QoQ | 205 286.8% YoY 135.6% QoQ | 63 5.0% YoY -69.3% QoQ |
| 2021 | 155 474.1% YoY 146.0% QoQ | 64 -26.4% YoY -58.7% QoQ | 50 -75.6% YoY -21.9% QoQ | 89 41.3% YoY 78.0% QoQ |
| 2022 | 43 -72.3% YoY -51.7% QoQ | 10 -84.4% YoY -76.7% QoQ | 72 44.0% YoY 620.0% QoQ | 65 -27.0% YoY -9.7% QoQ |
| 2023 | 47 9.3% YoY -27.7% QoQ | 36 260.0% YoY -23.4% QoQ | 99 37.5% YoY 175.0% QoQ | 93 43.1% YoY -6.1% QoQ |
| 2024 | 47 0.0% YoY -49.5% QoQ | - | - | - |
The average 5 years interest of Fennec Pharmaceuticals was 5.45 per week. The last year interest of Fennec Pharmaceuticals compared to the last 5 years has changed by 0.92%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 67.17%.
There is not enough data for Fennec Pharmaceuticals PEDMARK to provide analysis
There is not enough data for Fennec Pharmaceuticals PEDMARK to provide correlation calculation
There is not enough data for Fennec Pharmaceuticals PEDMARK to provide analysis
There is not enough data for Fennec Pharmaceuticals stock price to provide analysis
There is not enough data for Fennec Pharmaceuticals stock price to provide correlation calculation
There is not enough data for Fennec Pharmaceuticals stock price to provide analysis
After 39 days of this quarter the interest is at 100.0. Based on that we can calculate that during remaining 52 days it will total up to 233.0. Fennec Pharmaceuticals news expected interest is significantly higher compared to previous quarter (+5725.0%) and same quarter last year (+1126.3%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 15 | 9 -40.0% QoQ | 13 44.4% QoQ | 34 161.5% QoQ |
| 2020 | 9 -40.0% YoY -73.5% QoQ | 11 22.2% YoY 22.2% QoQ | 21 61.5% YoY 90.9% QoQ | 15 -55.9% YoY -28.6% QoQ |
| 2021 | 14 55.6% YoY -6.7% QoQ | 37 236.4% YoY 164.3% QoQ | 6 -71.4% YoY -83.8% QoQ | 29 93.3% YoY 383.3% QoQ |
| 2022 | 16 14.3% YoY -44.8% QoQ | 16 -56.8% YoY 0.0% QoQ | 8 33.3% YoY -50.0% QoQ | 24 -17.2% YoY 200.0% QoQ |
| 2023 | 19 18.8% YoY -20.8% QoQ | 11 -31.2% YoY -42.1% QoQ | 18 125.0% YoY 63.6% QoQ | 4 -83.3% YoY -77.8% QoQ |
| 2024 | 100 426.3% YoY 2400.0% QoQ | - | - | - |
The average 5 years interest of Fennec Pharmaceuticals news was 1.64 per week. The last year interest of Fennec Pharmaceuticals news compared to the last 5 years has changed by 72.56%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 106.57%.
There is not enough data for Fennec Pharmaceuticals clinical trials to provide analysis
There is not enough data for Fennec Pharmaceuticals clinical trials to provide correlation calculation
There is not enough data for Fennec Pharmaceuticals clinical trials to provide analysis
There is not enough data for Fennec Pharmaceuticals oncology to provide analysis
There is not enough data for Fennec Pharmaceuticals oncology to provide correlation calculation
There is not enough data for Fennec Pharmaceuticals oncology to provide analysis
There is not enough data for Fennec Pharmaceuticals Research Triangle Park to provide analysis
There is not enough data for Fennec Pharmaceuticals Research Triangle Park to provide correlation calculation
There is not enough data for Fennec Pharmaceuticals Research Triangle Park to provide analysis
After 39 days of this quarter the interest is at 100.0. Based on that we can calculate that during remaining 52 days it will total up to 233.0. Fennec Pharmaceuticals -company -stock expected interest is significantly higher compared to previous quarter (+348.1%) and same quarter last year (+482.5%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 10 | 55 450.0% QoQ | 30 -45.5% QoQ | 20 -33.3% QoQ |
| 2020 | 29 190.0% YoY 45.0% QoQ | 57 3.6% YoY 96.6% QoQ | 86 186.7% YoY 50.9% QoQ | 58 190.0% YoY -32.6% QoQ |
| 2021 | 57 96.6% YoY -1.7% QoQ | 27 -52.6% YoY -52.6% QoQ | 48 -44.2% YoY 77.8% QoQ | 39 -32.8% YoY -18.8% QoQ |
| 2022 | 28 -50.9% YoY -28.2% QoQ | 47 74.1% YoY 67.9% QoQ | 7 -85.4% YoY -85.1% QoQ | 41 5.1% YoY 485.7% QoQ |
| 2023 | 40 42.9% YoY -2.4% QoQ | 43 -8.5% YoY 7.5% QoQ | 53 657.1% YoY 23.3% QoQ | 52 26.8% YoY -1.9% QoQ |
| 2024 | 100 150.0% YoY 92.3% QoQ | - | - | - |
The average 5 years interest of Fennec Pharmaceuticals -company -stock was 3.55 per week. The last year interest of Fennec Pharmaceuticals -company -stock compared to the last 5 years has changed by 37.46%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 90.62%.
There is not enough data for Fennec Pharmaceuticals salary to provide analysis
There is not enough data for Fennec Pharmaceuticals salary to provide correlation calculation
There is not enough data for Fennec Pharmaceuticals salary to provide analysis
There is not enough data for Fennec Pharmaceuticals side effects to provide analysis
There is not enough data for Fennec Pharmaceuticals side effects to provide correlation calculation
There is not enough data for Fennec Pharmaceuticals side effects to provide analysis